Tell your healthcare provider about any kidney problems
Semaglutide is the active ingredient in brand-name medications including Ozempic and Wegovy
We recognize the challenge of maintaining weight loss long-term and are encouraged by the potential of Tirzepatide to support patients beyond initial weight reduction phases
Engaging this receptor triggers cytoprotective and anti-inflammatory signaling in injured tissue without stimulating red-blood-cell production [5] [6]
Neves JS, Borges-Canha M, Vasques-Nvoa F, Green JB, Leiter LA, Granger CB, Carvalho D, Leite-Moreira A, Hernandez AF, Del Prato S, et al
"Semaglutide and cardiovascular outcomes in obesity without diabetes." N Engl J Med